Male Yeast Infections Treatment Guideline
Diagnosis and Treatment
- The recommended treatment for male yeast infections is fluconazole 150 mg as a single oral dose, with additional doses given every 72 hours for a total of 2-3 doses in severe cases, as suggested by the Clinical Infectious Diseases guidelines 1
- Proper diagnosis is essential before initiating treatment, and should include symptoms such as redness, itching, burning sensation, and white patches on the genital area, as well as microscopic examination using potassium hydroxide (KOH) preparation to visualize yeast or hyphae 1
- First-line therapy is a single 150 mg oral dose of fluconazole, with alternative options including topical antifungal agents such as clotrimazole or miconazole applied to affected areas twice daily for 7-14 days 1
- For suspected C. glabrata infections, which may be fluconazole-resistant, consider topical boric acid (600 mg daily for 14 days) or alternative Nystatin topical application daily for 14 days 1
Treatment Duration and Dosage
- Fluconazole 150 mg every 72 hours for a total of 2-3 doses is recommended for severe cases, with treatment continued until clinical resolution of symptoms 1
- For urinary tract involvement, fluconazole 200 mg (3 mg/kg) daily for 2 weeks is recommended for symptomatic cystitis, and fluconazole 200-400 mg (3-6 mg/kg) daily for 2 weeks for pyelonephritis 2
- Initial induction therapy with fluconazole 150 mg daily for 10-14 days, followed by maintenance therapy with fluconazole 150 mg weekly for 6 months, is recommended for recurrent cases 2, 1
Prevention and Management
- Maintaining good genital hygiene, wearing loose-fitting cotton underwear, and avoiding prolonged moisture in the genital area can help prevent male yeast infections 1
- Prompt treatment of underlying conditions, such as diabetes, and consideration of prophylactic therapy in recurrent cases, can also help manage male yeast infections 1
- The Clinical Infectious Diseases guidelines recommend considering screening for diabetes or immunosuppression in recurrent cases, as well as evaluating sexual partners for candidiasis 1